Eli Lilly Just Hit a Milestone That Disappointed. Here's Why You Should Still Buy the Stock.

Even a juggernaut like Eli Lilly (NYSE: LLY) can miss the mark sometimes. When it reported its third-quarter earnings on Oct. 30, its share price plunged to the tune of 11% before recovering somewhat, signaling that the market's reception to its financial performance was strongly negative.Shareholders discovered that there's reason to believe that a previously hypothesized risk is now real and that it presents a possible threat to the stock's prior outstanding performance. Yet the stock is still unambiguously one of the better investments available right now.Here's what happened and why Eli Lilly stock is still worth buying.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool